145 related articles for article (PubMed ID: 19179908)
1. Prolonged remission of disseminated atypical adenomatous hyperplasia under gefitinib.
Pastorino U; Calabrò E; Tamborini E; Marchianò A; Orsenigo M; Fabbri A; Sozzi G; Novello S; De Marinis F
J Thorac Oncol; 2009 Feb; 4(2):266-7. PubMed ID: 19179908
[TBL] [Abstract][Full Text] [Related]
2. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.
Yoshida Y; Shibata T; Kokubu A; Tsuta K; Matsuno Y; Kanai Y; Asamura H; Tsuchiya R; Hirohashi S
Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread.
Chung JH; Choe G; Jheon S; Sung SW; Kim TJ; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2009 Dec; 4(12):1490-5. PubMed ID: 19844187
[TBL] [Abstract][Full Text] [Related]
4. Response to gefitinib in bronchioloalveolar carcinoma in the absence of EGFR mutation.
Taja-Chayeb L; Candelaria M; Brom R; Trejo-Becerril C; Meza F; Duenas-Gonzalez A
Lung Cancer; 2005 Nov; 50(2):259-63. PubMed ID: 16009451
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung.
Yoo SB; Chung JH; Lee HJ; Lee CT; Jheon S; Sung SW
J Thorac Oncol; 2010 Jul; 5(7):964-9. PubMed ID: 20512074
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor mutations in multicentric lung adenocarcinomas and atypical adenomatous hyperplasias.
Ikeda K; Nomori H; Ohba Y; Shibata H; Mori T; Honda Y; Iyama K; Kobayashi T
J Thorac Oncol; 2008 May; 3(5):467-71. PubMed ID: 18448997
[TBL] [Abstract][Full Text] [Related]
7. Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study.
Hirsch FR; Varella-Garcia M; McCoy J; West H; Xavier AC; Gumerlock P; Bunn PA; Franklin WA; Crowley J; Gandara DR;
J Clin Oncol; 2005 Oct; 23(28):6838-45. PubMed ID: 15998906
[TBL] [Abstract][Full Text] [Related]
8. Predictors of the response to gefitinib in refractory non-small cell lung cancer.
Kim KS; Jeong JY; Kim YC; Na KJ; Kim YH; Ahn SJ; Baek SM; Park CS; Park CM; Kim YI; Lim SC; Park KO
Clin Cancer Res; 2005 Mar; 11(6):2244-51. PubMed ID: 15788673
[TBL] [Abstract][Full Text] [Related]
9. Unusual chemosensitivity of advanced bronchioalveolar carcinoma after gefitinib response and progression: a case report.
Dziadziuszko R; Siemiatkowska A; Limon J; Rzyman W; Jassem J; Bunn PA; Varella-Garcia M; Hirsch FR
J Thorac Oncol; 2007 Jan; 2(1):91-2. PubMed ID: 17410018
[TBL] [Abstract][Full Text] [Related]
10. [Gefitinib for advanced bronchioloalveolar carcinoma].
Zhang XT; Wang SL; Li LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):340-3. PubMed ID: 15266843
[TBL] [Abstract][Full Text] [Related]
11. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
[TBL] [Abstract][Full Text] [Related]
12. Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung.
Kozuki T; Hisamoto A; Tabata M; Takigawa N; Kiura K; Segawa Y; Nakata M; Mandai K; Eguchi K; Ueoka H; Tanimoto M
Lung Cancer; 2007 Oct; 58(1):30-5. PubMed ID: 17561305
[TBL] [Abstract][Full Text] [Related]
13. IFCT-0401 Trial: a phase II study of gefitinib administered as first-line treatment in advanced adenocarcinoma with bronchioloalveolar carcinoma subtype.
Cadranel J; Quoix E; Baudrin L; Mourlanette P; Moro-Sibilot D; Morere JF; Souquet PJ; Soria JC; Morin F; Milleron B;
J Thorac Oncol; 2009 Sep; 4(9):1126-35. PubMed ID: 19574932
[TBL] [Abstract][Full Text] [Related]
14. Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs.
Kohno T; Kakinuma R; Iwasaki M; Yamaji T; Kunitoh H; Suzuki K; Shimada Y; Shiraishi K; Kasuga Y; Hamada GS; Furuta K; Tsuta K; Sakamoto H; Kuchiba A; Yamamoto S; Kanai Y; Tsugane S; Yokota J
Carcinogenesis; 2010 Oct; 31(10):1794-9. PubMed ID: 20688833
[TBL] [Abstract][Full Text] [Related]
15. Prompt control of bronchorrhea in patients with bronchioloalveolar carcinoma treated with gefitinib (Iressa).
Milton DT; Kris MG; Gomez JE; Feinstein MB
Support Care Cancer; 2005 Jan; 13(1):70-2. PubMed ID: 15558327
[TBL] [Abstract][Full Text] [Related]
16. Short-term gefitinib treatment brought about a long-term regression of bronchioloalveolar carcinoma without EGFR gene alterations: a case report.
Kijima T; Suzuki M; Ueda K; Minami S; Takeda Y; Goya S; Matsuoka H; Kumagai T; Yoshida M; Osaki T; Tachibana I; Yokota S; Kawase I
Oncol Res; 2007; 16(10):489-95. PubMed ID: 18196873
[TBL] [Abstract][Full Text] [Related]
17. Differentiating between atypical adenomatous hyperplasia and bronchioloalveolar carcinoma using the computed tomography number histogram.
Nomori H; Ohtsuka T; Naruke T; Suemasu K
Ann Thorac Surg; 2003 Sep; 76(3):867-71. PubMed ID: 12963218
[TBL] [Abstract][Full Text] [Related]
18. Monoclonality of atypical adenomatous hyperplasia of the lung.
Niho S; Yokose T; Suzuki K; Kodama T; Nishiwaki Y; Mukai K
Am J Pathol; 1999 Jan; 154(1):249-54. PubMed ID: 9916939
[TBL] [Abstract][Full Text] [Related]
19. [High-resolution CT findings of pulmonary atypical adenomatous hyperplasia of 5 mm or less in diameter].
Ishikawa H; Koizumi N; Naito M; Umezu H; Morita T; Nemoto T; Saito T; Okuizumi M; Sasai K
Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Jul; 63(6):311-5. PubMed ID: 12934549
[TBL] [Abstract][Full Text] [Related]
20. Lung adenocarcinoma with bronchioloalveolar carcinoma component is frequently associated with foci of high-grade atypical adenomatous hyperplasia.
Koga T; Hashimoto S; Sugio K; Yonemitsu Y; Nakashima Y; Yoshino I; Matsuo Y; Mojtahedzadeh S; Sugimachi K; Sueishi K
Am J Clin Pathol; 2002 Mar; 117(3):464-70. PubMed ID: 11888087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
